Cipla gains on resolving funding dispute with US-based Pulmatrix

The funding tussle with Pulmatrix Inc was regarding the development of Pulmazole, an asthma medication that is currently under development.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3wEtb0v
via IFTTT